Applied DNA Sciences Inc
APDN4.230USD
-0.340-7.44%
交易中 （美東）報價延遲15分鐘
1.79M總市值
虧損本益比TTM
關於 Applied DNA Sciences Inc 公司
Applied DNA Sciences, Inc. 是一家生物技術公司。該公司致力於開發和商業化生產和檢測脫氧核糖核酸 (DNA) 和核糖核酸 (RNA) 的技術。該公司通過三個部門運營：治療性 DNA 生產服務、MDx 檢測服務以及 DNA 標記和安全產品和服務。治療性 DNA 生產服務部門的業務包括酶促製造合成 DNA 用於生產基於核酸的療法，以及開發和銷售專有 RNAP 用於生產信使 RNA (mRNA) 療法。MDx 檢測服務部門的業務包括執行和開發臨牀分子診斷和基因測試以及臨牀實驗室檢測服務。DNA 標記和安全產品和服務部門的業務包括爲工業供應鏈和安全服務製造和檢測 DNA。
公司簡介
公司代碼APDN
公司名稱Applied DNA Sciences Inc
上市日期Aug 24, 2001
CEOMs. Judith Murrah
員工數量46
證券類型Ordinary Share
年結日Aug 24
公司地址50 Health Sciences Drive
城市STONY BROOK
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編11790
電話16312408800
網址https://adnas.com/
公司代碼APDN
上市日期Aug 24, 2001
CEOMs. Judith Murrah
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
President of LRx
President of LRx
4.00
--
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
3.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
3.00
--
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
2.00
--
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
2.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Elizabeth M. Schmalz Shaheen
Ms. Elizabeth M. Schmalz Shaheen
Independent Director
Independent Director
--
--
Dr. Sanford R. Simon, Ph.D.
Dr. Sanford R. Simon, Ph.D.
Independent Director
Independent Director
--
--
Mr. Sanjay M. Hurry
Mr. Sanjay M. Hurry
Executive Director - Investor Relations and Corporate Communications
Executive Director - Investor Relations and Corporate Communications
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
President of LRx
President of LRx
4.00
--
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
3.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
3.00
--
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
2.00
--
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
2.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Product and authentication services - Large scale DNA production
333.66K
33.93%
Product and authentication services - Supply chain
290.23K
29.51%
Clinical laboratory testing services (over-time)
220.55K
22.43%
Research and development services
133.55K
13.58%
Product and authentication services - Asset marking
5.38K
0.55%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
Product and authentication services - Large scale DNA production
333.66K
33.93%
Product and authentication services - Supply chain
290.23K
29.51%
Clinical laboratory testing services (over-time)
220.55K
22.43%
Research and development services
133.55K
13.58%
Product and authentication services - Asset marking
5.38K
0.55%
股東統計
更新時間: 7月19日 週六
更新時間: 7月19日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Sabby Management, LLC
1.34%
Altium Capital Management LP
1.25%
S.H.N. Financial Investments Ltd
0.97%
Bigger (Michael)
0.96%
Anson Funds Management LP.
0.88%
Other
94.60%
持股股東
持股股東
佔比
Sabby Management, LLC
1.34%
Altium Capital Management LP
1.25%
S.H.N. Financial Investments Ltd
0.97%
Bigger (Michael)
0.96%
Anson Funds Management LP.
0.88%
Other
94.60%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
2.59%
Corporation
1.77%
Individual Investor
0.99%
Hedge Fund
0.89%
Investment Advisor
0.45%
Research Firm
0.03%
Other
93.28%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
62
34.90K
6.72%
-9.01K
2025Q1
84
45.20K
34.86%
+11.50K
2024Q4
79
25.60M
46.39%
+1.44M
2024Q3
74
1.08M
9.78%
+703.30K
2024Q2
73
1.19M
10.83%
+424.27K
2024Q1
67
243.32K
209.10%
+86.27K
2023Q4
64
96.98K
13.46%
-84.74K
2023Q3
66
149.12K
21.28%
-82.31K
2023Q2
68
142.47K
21.43%
-74.27K
2023Q1
68
128.77K
20.06%
-84.88K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Sabby Management, LLC
6.97K
1.34%
+1.29K
+22.64%
Dec 31, 2024
Altium Capital Management LP
6.50K
1.25%
--
--
Apr 03, 2025
S.H.N. Financial Investments Ltd
5.03K
0.97%
--
--
Apr 03, 2025
Bigger (Michael)
5.00K
0.96%
--
--
Apr 03, 2025
Anson Funds Management LP.
4.57K
0.88%
-9.44K
-67.39%
Apr 03, 2025
L1 Capital Global Opportunities Master Fund Ltd.
4.17K
0.8%
--
--
Apr 03, 2025
UBS Financial Services, Inc.
2.31K
0.44%
+2.31K
--
Mar 31, 2025
Grossman (Bruce)
111.00
0.02%
+111.00
--
Feb 02, 2024
Barclays Capital Inc.
80.00
0.02%
+80.00
--
Mar 31, 2025
SBI Securities Co., Ltd.
67.00
0.01%
-90.00
-57.32%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Mar 12, 2025
Merger
50<1
Mar 12, 2025
Merger
50<1
Mar 12, 2025
Merger
50<1
Mar 12, 2025
Merger
50<1
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
公告日期
類型
比率
Mar 12, 2025
Merger
50<1
Mar 12, 2025
Merger
50<1
Mar 12, 2025
Merger
50<1
Mar 12, 2025
Merger
50<1
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
